Theodore James Washburn Jr.

Companies

• Agios PharmaceuticalsPrincipal Accounting Officer Aug 5, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Agios Pharmaceuticals AGIO868 shares²$29.8K at $34.36Mar 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 3, 2026Sold 5,272 shares at $28.88 of Agios Pharmaceuticals²
• Mar 2, 2026Sold 798 shares at $28.96 of Agios Pharmaceuticals³
• Mar 2, 2026Exercised options 2,695 shares of Agios Pharmaceuticals³
• Mar 2, 2026Sold 727 shares at $28.96 of Agios Pharmaceuticals³
• Mar 2, 2026Exercised options 2,450 shares of Agios Pharmaceuticals³
• Mar 2, 2026Sold 698 shares at $28.96 of Agios Pharmaceuticals³
• Mar 2, 2026Exercised options 2,350 shares of Agios Pharmaceuticals³
• Sep 5, 2025Sold 8,546 shares at $36.87 of Agios Pharmaceuticals⁴
• Mar 3, 2025Sold 727 shares at $35.54 of Agios Pharmaceuticals⁵
• Mar 3, 2025Sold 697 shares at $35.54 of Agios Pharmaceuticals⁵
• Mar 3, 2025Sold 231 shares at $35.54 of Agios Pharmaceuticals⁵
• Mar 1, 2025Exercised options 2,450 shares of Agios Pharmaceuticals⁵
• Mar 1, 2025Exercised options 2,350 shares of Agios Pharmaceuticals⁵
• Mar 1, 2025Exercised options 777 shares of Agios Pharmaceuticals⁵
• Feb 5, 2025Sold 2,272 shares at $34.39 of Agios Pharmaceuticals⁶
• Feb 1, 2025Exercised options 6,896 shares of Agios Pharmaceuticals⁶
• Nov 8, 2024Sold 772 shares at $56.09 of Agios Pharmaceuticals⁷
• Jun 3, 2024Sold 1,362 shares at $44.39 of Agios Pharmaceuticals⁸
• Mar 5, 2024Sold 919 shares at $32.57 of Agios Pharmaceuticals⁹
• Mar 5, 2024Sold 295 shares at $32.57 of Agios Pharmaceuticals⁹
• Mar 5, 2024Sold 1,913 shares at $31.75 of Agios Pharmaceuticals¹⁰
• Mar 1, 2024Exercised options 2,350 shares of Agios Pharmaceuticals⁹
• Mar 1, 2024Exercised options 777 shares of Agios Pharmaceuticals⁹
• Feb 20, 2024Sold 504 shares at $26.63 of Agios Pharmaceuticals¹¹
• Feb 14, 2024Sold 273 shares at $25.14 of Agios Pharmaceuticals¹²